Search research articles
Contact Us
Filters
Showing results (31-40 of 516) with videos related to
Page
of 52
Sort By:
The Journal of Urology
|
May 13, 2026
Interpreting Matched Analyses of Partial Versus Radical Nephrectomy for cT2 Tumors: Methodological Caveats and Clinical Implications
Umberto Capitanio, Francesco Cei, Alessandro Larcher, et al.
Urologic Oncology
|
June 1, 2022
Reply to Sebastiano Buti and Giulia Claire Giudice's Letter to the Editor comparing the prognostic models to predict oncologic outcomes in patients with renal cell carcinoma: Is AUC close enough to clinical practice? Urol Oncol. 2022 Apr 14:S1078-1439(22)00066-7. doi: 10.1016/j.urolonc.2022.02.015
Giuseppe Rosiello, Alessandro Larcher, Francesco Montorsi, et al.
European Urology
|
February 10, 2018
You Can Trust a Crystal Ball About as Far as You Can Throw It
Umberto Capitanio, Alessandro Larcher, Francesco Montorsi, et al.
European Urology
|
October 4, 2016
Re: Brian I. Rini, Tanya B. Dorff, Paul Elson, et al. Active Surveillance in Metastatic Renal-cell Carcinoma: A Prospective, Phase 2 Trial. Lancet Oncol Lancet 2016;17:1317-24: Active Surveillance in Metastatic Renal Cell Carcinoma: Option or Exception?
Umberto Capitanio, Alessandro Larcher, Paolo Dell'Oglio, et al.
European Urology
|
October 15, 2022
Long-distance Robot-assisted Teleoperation: Every Millisecond Counts
Alessandro Larcher, Federico Belladelli, Umberto Capitanio, et al.
European Urology
|
March 14, 2022
Re: Sarah P. Psutka, Roman Gulati, Michael A.S. Jewett, et al. A Clinical Decision Aid to Support Personalized Treatment Selection for Patients with Clinical T1 Renal Masses: Results from a Multi-institutional Competing-risks Analysis. Eur Urol. 2022;81:576-85
Francesco Montorsi, Umberto Capitanio, Giuseppe Rosiello, et al.
European Urology
|
March 6, 2022
Neoadjuvant Treatment in Renal Cell Carcinoma: Transforming Challenges into Opportunities
Laura Marandino, Daniele Raggi, Andrea Necchi, et al.
World Journal of Urology
|
August 12, 2021
Renal cancer: overdiagnosis and overtreatment
Giuseppe Rosiello, Alessandro Larcher, Francesco Montorsi, et al.
European Urology
|
May 2, 2016
Reply to Kazutaka Saito's Words of Wisdom re: Nephron-sparing Techniques Independently Decrease the Risk of Cardiovascular Events Relative to Radical Nephrectomy in Patients with a T1a-T1b Renal Mass and Normal Preoperative Renal Function. Eur Urol. 2016;69:538
Umberto Capitanio, Paolo Dell'Oglio, Alessandro Larcher, et al.
European Urology
|
June 30, 2022
Reply to Yongbao Wei, Ruochen Zhang, and Le Lin's Letter to the Editor re: Börje Ljungberg, Laurence Albiges, Yasmin Abu-Ghanem, et al. European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 Update. Eur Urol. 2022;82:e88
Börje Ljungberg, Jens Bedke, Umberto Capitanio, et al.
Page
of 52
Search research articles
Search
Showing results (31-40 of 516) with videos related to
Sort By:
Page
of 52
The Journal of Urology
|
May 13, 2026
Interpreting Matched Analyses of Partial Versus Radical Nephrectomy for cT2 Tumors: Methodological Caveats and Clinical Implications
Umberto Capitanio, Francesco Cei, Alessandro Larcher, et al.
Urologic Oncology
|
June 1, 2022
Reply to Sebastiano Buti and Giulia Claire Giudice's Letter to the Editor comparing the prognostic models to predict oncologic outcomes in patients with renal cell carcinoma: Is AUC close enough to clinical practice? Urol Oncol. 2022 Apr 14:S1078-1439(22)00066-7. doi: 10.1016/j.urolonc.2022.02.015
Giuseppe Rosiello, Alessandro Larcher, Francesco Montorsi, et al.
European Urology
|
February 10, 2018
You Can Trust a Crystal Ball About as Far as You Can Throw It
Umberto Capitanio, Alessandro Larcher, Francesco Montorsi, et al.
European Urology
|
October 4, 2016
Re: Brian I. Rini, Tanya B. Dorff, Paul Elson, et al. Active Surveillance in Metastatic Renal-cell Carcinoma: A Prospective, Phase 2 Trial. Lancet Oncol Lancet 2016;17:1317-24: Active Surveillance in Metastatic Renal Cell Carcinoma: Option or Exception?
Umberto Capitanio, Alessandro Larcher, Paolo Dell'Oglio, et al.
European Urology
|
October 15, 2022
Long-distance Robot-assisted Teleoperation: Every Millisecond Counts
Alessandro Larcher, Federico Belladelli, Umberto Capitanio, et al.
European Urology
|
March 14, 2022
Re: Sarah P. Psutka, Roman Gulati, Michael A.S. Jewett, et al. A Clinical Decision Aid to Support Personalized Treatment Selection for Patients with Clinical T1 Renal Masses: Results from a Multi-institutional Competing-risks Analysis. Eur Urol. 2022;81:576-85
Francesco Montorsi, Umberto Capitanio, Giuseppe Rosiello, et al.
European Urology
|
March 6, 2022
Neoadjuvant Treatment in Renal Cell Carcinoma: Transforming Challenges into Opportunities
Laura Marandino, Daniele Raggi, Andrea Necchi, et al.
World Journal of Urology
|
August 12, 2021
Renal cancer: overdiagnosis and overtreatment
Giuseppe Rosiello, Alessandro Larcher, Francesco Montorsi, et al.
European Urology
|
May 2, 2016
Reply to Kazutaka Saito's Words of Wisdom re: Nephron-sparing Techniques Independently Decrease the Risk of Cardiovascular Events Relative to Radical Nephrectomy in Patients with a T1a-T1b Renal Mass and Normal Preoperative Renal Function. Eur Urol. 2016;69:538
Umberto Capitanio, Paolo Dell'Oglio, Alessandro Larcher, et al.
European Urology
|
June 30, 2022
Reply to Yongbao Wei, Ruochen Zhang, and Le Lin's Letter to the Editor re: Börje Ljungberg, Laurence Albiges, Yasmin Abu-Ghanem, et al. European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 Update. Eur Urol. 2022;82:e88
Börje Ljungberg, Jens Bedke, Umberto Capitanio, et al.
Page
of 52